Michaël Doumen

MD PhD. Rheumatology resident & clinical researcher at KU Leuven: focus on RA, patient-reported outcomes and mHealth. Above all: husband, father.

[Michaël Doumen @DoumenMichael]

❗#BMCRheumatology has just launched a call for papers on the diagnosis and treatment of #rheumatoidarthritis! As Guest Editor for this Collection, I invite all interested researchers to consider submitting their work 💪

👉https://t.co/OhDvyj1MM8
@BioMedCentral @BMC_series

[Michaël Doumen @DoumenMichael]

Yesterday was special! I was honoured to defend my PhD in front of family, friends and promotors, with the incredible @ndosie, @LGossec and prof. Peter Taylor as jury members, and @KU_Leuven’s own @TissueHomandDis as chairman. #PhDone 🎉

[Michaël Doumen @DoumenMichael]

❗Excited to share our work on pt-physician discordance and T2T in a #RheumatoidArthritis trial

➡️T2T implementation 👇 when not protocolized and with☝️discordance
↪️👇remission rates,☝️HAQ, no effect on Rx progression

👉https://t.co/KVsBMEGPmb
@RheumJnl #RheumTwitter

[Rheumatology & Rheumatology Advances in Practice @RheumJnl]

Guest edited by the fab @ElenaNikiUK, our new special issue features the latest research on comorbidities in #RheumatoidArthritis.

This issue covers neuropsychiatry, mental health, lung disease, infections, polypharmacy... the list goes on!

Read now 👉 https://t.co/3SMBio8Q1g

[Michaël Doumen @DoumenMichael]

Congratulations to my wonderful colleague Delphine Bertrand for presenting the first results of our CareRA2020 trial at #EULAR2023. More to come!

[Michaël Doumen @DoumenMichael]

@DrSarahBennett @FerreiraRJO @eularHPR Congratulations @FerreiraRJO , well deserved 👌

[Michaël Doumen @DoumenMichael]

✈️ into Milan for #EULAR2023. First stop: the poster hall. Come say hi at poster POS0483 from 3:30 PM 👋

[Janet Pope @Janetbirdope]

#ClinicalPearl Fatigue in #rheumatoid #arthritis is an epidemic. We need research to help treat residual fatigue in RA #ORA23 @DrReuma

[Ricardo ferreira @FerreiraRJO]

✍️𝗙𝗿𝗲𝗲: 𝗹𝗶𝗺𝗶𝘁𝗲𝗱 𝘁𝗼 𝟮𝟬 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 (PhD students OR Júnior Post-Doc)

+Info: https://t.co/3esi655jd9

#EEAGrants #EEAGrantsPT #EEANorwayGrants #CIDNUR #tractionproject #REMEDY

[Chris Wincup @chriswincup]

🧵 Short summary thread on our recent publication looking at the impact of Anti-Rituximab Antibodies in #SLE with our recent manuscript published in @RheumJnl

This has been a story that we have been looking at for a few years now

💻 Link - https://t.co/SrbnPLv4bC

[Michaël Doumen @DoumenMichael]

@NoContextBrits @sophie_33pl

[David Liew @drdavidliew]

What imaging modality is best in GCA?

Dutch study: n=42
?GCA got all three of USS, PET/CT, MRI

Overall performance basically the same between all three.

Important details in 🧵
but reasonable to say you can be happy with whatever you’ve got!

ABST1617 #ACR22 #ACRBest @RheumNow

[Michaël Doumen @DoumenMichael]

@DiederikDeCock @Kasterlee Well done Stijn! 👌

[EMEUNET @EMEUNET]

The #EMEUNET networking event at #ACR22 in Philadelphia is getting underway! 🎉

@k_lauper @FeliceRivellese @ProftDr @Ertugrul_cagri @IzukaShinji @DrMiniDey

[Michaël Doumen @DoumenMichael]

@FerreiraRJO Definitely we should!

[Michaël Doumen @DoumenMichael]

Arrived in Philadelphia nice and early for #ACR22 . Looking forward!

[Michaël Doumen @DoumenMichael]

@DiederikDeCock
@sophie_33pl
@Will_I_Am_Osler

[Michaël Doumen @DoumenMichael]

🆕 Happy to share our systematic review and MA in @ARD_BMJ on patient engagement with #eHealth in chronic #arthritis.

✅Generally high reported engagement rates
❗️Varying attrition over time
❔ Relative lack of real-world data

➡️https://t.co/JFKA5Xxjv7

[EULAR @eular_org]

📢 NEW! Register for the 1st #EULAR Online Course for Patient Research Partners, for people with rheumatic and #musculoskeletal diseases

Register here 👉 https://t.co/s4agttVcH9
📆 Deadline: 30 November

#eularEDUCATION #eularPARE #EULAROnlineCourses #rheumatoidarthritis #rheuma